Works matching DE "DEFERASIROX"

Results: 336

铁棍/佛手山药粗多糖的抗糖尿病作用效果比较.

Published in:

Modern Food Science & Technology, 2022, v. 38, n. 4, p. 10, doi. 10.13982/j.mfst.1673-9078.2022.4.0519

By:

蔡羽;
植飞;
陈运中;
刘思敏;
颜春潮;
万未希;
佘雅茹;
曾珉

Publication type:

Article

Deferasirox Causes Leukaemia Cell Death through Nrf2-Induced Ferroptosis.

Published in:

Antioxidants, 2024, v. 13, n. 4, p. 424, doi. 10.3390/antiox13040424

By:

Hsu, Wan-Yi;
Wang, Li-Ting;
Lin, Pei-Chin;
Liao, Yu-Mei;
Hsu, Shih-Hsien;
Chiou, Shyh-Shin

Publication type:

Article

In vitro Studying of Deferasirox Side effects on the Structure and the Function of Bovine Liver Catalase.

Published in:

Journal of Fasa University of Medical Sciences, 2014, v. 4, n. 3, p. 258

By:

Moradi, M.;
Divsalar, A.;
Saeidifar, M.;
Saboury, A. A.;
Tahmaseb, M.

Publication type:

Article

Acute liver failure in a pediatric patient with congenital dyserythropoietic anemia type I treated with deferasirox.

Published in:

2015

By:

Ling, Galina;
Pinsk, Vered;
Golan-Tripto, Inbal;
Ling, Eduard

Publication type:

Case Study

The synthesis and antibacterial activity evaluation of oxazolidinone - deferasirox conjugates.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 12, p. 946, doi. 10.5246/jcps.2022.12.080

By:

Xintong Zhao;
Yuhua Hu;
Tong Qin;
Tianlei Li;
Wenxuan Zhang;
Song Wu

Publication type:

Article

Deferasirox: appraisal of safety and efficacy in long-term therapy.

Published in:

Journal of Blood Medicine, 2013, v. 4, p. 101, doi. 10.2147/JBM.S35478

By:

Chaudhary, Preeti;
Pullarkat, Vinod

Publication type:

Article

Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England.

Published in:

2018

By:

Osborne, Vicki;
Davies, Miranda;
Layton, Deborah;
Shakir, Saad A. W.

Publication type:

journal article

Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox: A Case Report.

Published in:

2016

By:

Önal, Uğur;
Taşbakan, Meltem;
Yamazhan, Tansu;
Arda, Bilgin;
Pullukçu, Hüsnü;
Ulusoy, Sercan;
Sipahi, Oğuz Reşat

Publication type:

Case Study

Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results fromthe EPIC Clinical Trial.

Published in:

Anemia (20901267), 2012, p. 1, doi. 10.1155/2012/297641

By:

Porter, John;
Bowden, Donald K.;
Economou, Marina;
Troncy, Jacques;
Ganser, Arnold;
Habr, Dany;
Martin, Nicolas;
Gater, Adam;
Rofail, Diana;
Abetz-Webb, Linda;
Lau, Helen;
Cappellini, Maria Domenica

Publication type:

Article

Deferasirox Versus Deferoxiamine for the Treatment of Transfusional Iron Overload in Patients with β-Thalassemia Major.

Published in:

Ibnosina Journal of Medicine & Biomedical Sciences, 2014, v. 6, n. 1, p. 14, doi. 10.4103/1947-489X.210350

By:

Ibrahiem, Osama A.;
Thabet, Ahmad F.

Publication type:

Article

The Incidence of Ototoxicity in Patients Using Iron Chelators.

Published in:

Journal of International Advanced Otology, 2017, v. 13, n. 1, p. 136, doi. 10.5152/iao.2016.1852

By:

Derin, Serhan;
Azık, Fatih Mehmet;
Topal, Yaşar;
Topal, Hatice;
Karakuş, Volkan;
Çetinkaya, Petek Uzay;
Şahan, Murat;
Azık, Tansel Erdem;
Kocabaş, Can Naci

Publication type:

Article

Observational study comparing long-term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation-naïve children with transfusional iron overload.

Published in:

European Journal of Haematology, 2012, v. 88, n. 5, p. 431, doi. 10.1111/j.1600-0609.2012.01769.x

By:

Aydinok, Yesim;
Unal, Sule;
Oymak, Yesim;
Vergin, Canan;
Türker, Zeynep D.;
Yildiz, Dilek;
Yesilipek, Akif

Publication type:

Article

Deferasirox treatment of iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjange.

Published in:

European Journal of Haematology, 2012, v. 88, n. 3, p. 260, doi. 10.1111/j.1600-0609.2011.01726.x

By:

Gattermann, Norbert;
Jarisch, Andrea;
Schlag, Rudolf;
Blumenstengel, Klaus;
Goebeler, Mariele;
Groschek, Matthias;
Losem, Christoph;
Procaccianti, Maria;
Junkes, Alexia;
Leismann, Oliver;
Germing, Ulrich

Publication type:

Article

Achieving treatment goals of reducing or maintaining body iron burden with deferasirox in patients with β-thalassaemia: results from the ESCALATOR study.

Published in:

European Journal of Haematology, 2011, v. 87, n. 4, p. 349, doi. 10.1111/j.1600-0609.2011.01661.x

By:

Taher, Ali;
Elalfy, Mohsen S.;
Al Zir, Kusai;
Daar, Shahina;
Al Jefri, Abdullah;
Habr, Dany;
Kriemler-Krahn, Ulrike;
Roubert, Bernard;
El-Beshlawy, Amal

Publication type:

Article

Importance of optimal dosing ≥30 mg/kg/d during deferasirox treatment: 2.7-yr follow-up from the ESCALATOR study in patients with β-thalassaemia.

Published in:

European Journal of Haematology, 2011, v. 87, n. 4, p. 355, doi. 10.1111/j.1600-0609.2011.01662.x

By:

Taher, Ali;
Elalfy, Mohsen S.;
Al Zir, Kusai;
Daar, Shahina;
Al Jefri, Abdullah;
Habr, Dany;
Kriemler-Krahn, Ulrike;
El-Ali, Ali;
Roubert, Bernard;
El-Beshlawy, Amal

Publication type:

Article

Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias.

Published in:

European Journal of Haematology, 2011, v. 87, n. 4, p. 338, doi. 10.1111/j.1600-0609.2011.01660.x

By:

Porter, John B.;
Lin, Kai-Hsin;
Beris, Photis;
Forni, Gian Luca;
Taher, Ali;
Habr, Dany;
Domokos, Gabor;
Roubert, Bernard;
Thein, Swee Lay

Publication type:

Article

The impact of two different doses of chelating therapy (deferasirox) on echocardiographic tissue Doppler indices in patients with thalassemia major.

Published in:

European Journal of Haematology, 2011, v. 87, n. 3, p. 267, doi. 10.1111/j.1600-0609.2011.01641.x

By:

Garadah, Taysir S.;
Mahdi, Najat;
Kassab, Salah;
Abu-Taleb, Ahmed;
Shoroqi, Issa;
Alawadi, Abdul H.

Publication type:

Article

Elucidating the effect of iron acquisition systems in Klebsiella pneumoniae on susceptibility to the novel siderophore-cephalosporin cefiderocol.

Published in:

PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0277946

By:

Daoud, Lana;
Al-Marzooq, Farah;
Moubareck, Carole Ayoub;
Ghazawi, Akela;
Collyns, Timothy

Publication type:

Article

Development of Drug-Loaded Solid Self-Emulsifying System Based Orally Disintegrating Tablets for the Effectual Oral Delivery of Deferasirox.

Published in:

Indian Journal of Pharmaceutical Sciences, 2023, v. 85, n. 5, p. 1268

By:

SABLE, PREETI;
LAHOTI, S.;
GHADALINGE, S.

Publication type:

Article

Acute hyperammonemia in children under deferasirox treatment: cutting the Gordian knot.

Published in:

2019

By:

Martinelli, Diego;
Goffredo, Bianca Maria;
Stefania Falvella, Felicia;
Marano, Marco

Publication type:

Letter to the Editor

Biodegradation of Herbicides by a Plant Nonheme Iron Dioxygenase: Mechanism and Selectivity of Substrate Analogues.

Published in:

Chemistry - A European Journal, 2022, v. 28, n. 7, p. 1, doi. 10.1002/chem.202103982

By:

Lin, Yen‐Ting;
Ali, Hafiz S.;
de Visser, Sam P.

Publication type:

Article

Deferasirox-TAT(47-57) peptide conjugate as a water soluble, bifunctional iron chelator with potential use in neuromedicine.

Published in:

BioMetals, 2015, v. 28, n. 5, p. 869, doi. 10.1007/s10534-015-9873-5

By:

Goswami, Dibakar;
Vitorino, Hector;
Alta, Roxana;
Silvestre, Daniel;
Nomura, Cassiana;
Machini, M.;
Espósito, Breno

Publication type:

Article

Combined chelation of lead (II) by deferasirox and deferiprone in rats as biological model.

Published in:

BioMetals, 2014, v. 27, n. 1, p. 89, doi. 10.1007/s10534-013-9689-0

By:

Balooch, F.;
Fatemi, S.;
Iranmanesh, M.

Publication type:

Article

Treatment of mercury vapor toxicity by combining deferasirox and deferiprone in rats.

Published in:

BioMetals, 2013, v. 26, n. 5, p. 783, doi. 10.1007/s10534-013-9656-9

By:

Iranmanesh, Marzieh;
Fatemi, S.;
Golbafan, Mohammad;
Dahooee Balooch, Faezeh

Publication type:

Article

Chelation of chromium(VI) by combining deferasirox and deferiprone in rats.

Published in:

BioMetals, 2013, v. 26, n. 3, p. 465, doi. 10.1007/s10534-013-9631-5

By:

Iranmanesh, Marzieh;
Fatemi, S.;
Ebrahimpour, Roza;
Dahooee Balooch, Faezeh

Publication type:

Article

Clinical evaluation of Deferasirox for removal of cadmium ions in rat.

Published in:

BioMetals, 2010, v. 23, n. 4, p. 707, doi. 10.1007/s10534-010-9337-x

By:

Saljooghi, Amir;
Fatemi, S.

Publication type:

Article

Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG.

Published in:: BioMetals, 2010, v. 23, n. 2, p. 231, doi. 10.1007/s10534-009-9281-9
Publication type:: Article

Acute renal failure and Fanconi syndrome due to deferasirox.

Published in:

2010

By:

Grangé, Steven;
Bertrand, Dominique M.;
Guerrot, Dominique;
Eas, Florence;
Godin, Michel

Publication type:

Case Study

Removal of thallium by deferasirox in rats as biological model.

Published in:

Journal of Applied Toxicology, 2011, v. 31, n. 2, p. 139, doi. 10.1002/jat.1573

By:

Saljooghi, Amir Sh.;
Fatemi, S. Jamiladin

Publication type:

Article

Managing Iron Overload in Patients with Myelodysplastic Syndromes with Oral Deferasirox Therapy.

Published in:

Oncologist, 2009, v. 14, n. 5, p. 489, doi. 10.1634/theoncologist.2008-0154

By:

JABBOUR, ELIAS;
GARCIA-MANERO, GUILLERMO;
TAHER, ALI;
KANTARJIAN, HAGOP M.

Publication type:

Article

A Deferasirox Derivative That Acts as a Multifaceted Platform for the Detection and Quantification of Fe 3+.

Published in:

Chemosensors, 2021, v. 9, n. 4, p. 68, doi. 10.3390/chemosensors9040068

By:

Steinbrueck, Axel;
Sedgwick, Adam C.;
Hwang, Suh-Mi;
Sen, Sajal;
Zhao, Michael Y.;
Huang, Dan-Ying;
Knoll, Daniel M.;
Wang, Yu-Ying;
Sessler, Jonathan L.

Publication type:

Article

Wet Peroxide Oxidation of Paracetamol Using Acid Activated and Fe/Co-Pillared Clay Catalysts Prepared from Natural Clays.

Published in:

Catalysts (2073-4344), 2019, v. 9, n. 9, p. 705, doi. 10.3390/catal9090705

By:

Santos Silva, Adriano;
Seitovna Kalmakhanova, Marzhan;
Kabykenovna Massalimova, Bakytgul;
Juliana, G. Sgorlon;
Diaz de Tuesta, Jose Luis;
Gomes, Helder Teixeira

Publication type:

Article

The Impact of Type VI Secretion System, Bacteriocins and Antibiotics on Bacterial Competition of Pectobacterium carotovorum subsp. brasiliense and the Regulation of Carbapenem Biosynthesis by Iron and the Ferric-Uptake Regulator.

Published in:

Frontiers in Microbiology, 2019, p. 1, doi. 10.3389/fmicb.2019.02379

By:

Shyntum, Divine Yufetar;
Nkomo, Ntombikayise Precious;
Shingange, Ntwanano Luann;
Gricia, Alessandro Rino;
Bellieny-Rabelo, Daniel;
Moleleki, Lucy Novungayo

Publication type:

Article

Combination therapy - deferasirox and deferoxamine - in thalassemia major patients in emerging countries with limited resources.

Published in:

Transfusion Medicine, 2015, v. 25, n. 1, p. 8, doi. 10.1111/tme.12188

By:

Arandi, N.;
Haghpanah, S.;
Safaei, S.;
Zahedi, Z.;
Ashrafi, A.;
Eatemadfar, P.;
Zarei, T.;
Radwan, A. H;
Taher, A. T;
Karimi, M.

Publication type:

Article

Efficacy of Deferasirox for the treatment of iron overload in Chinese thalassaemia major patients: results from a prospective, open-label, multicentre clinical trial.

Published in:

Transfusion Medicine, 2013, v. 23, n. 6, p. 389, doi. 10.1111/tme.12077

By:

Lai, Y.‐R.;
Liu, R.‐R.;
Li, C.‐F.;
Huang, S.‐L.;
Li, Q.;
Habr, D.;
Martin, N.;
Shen, Z.‐X.

Publication type:

Article

An Iron-enhanced nanocone assisted drug delivery of Aspirin: DFT assessments.

Published in:

International Journal of Nano Dimension, 2023, v. 14, n. 4, p. 339

By:

Gol, Ali Ghasemi;
Akbari, Jafar;
Khalaj, Mehdi

Publication type:

Article

Preparation of Deferasirox in nano-scale by ultrasonic irradiation and optimization the amount and reaction time parameters.

Published in:

International Journal of Nano Dimension, 2015, v. 6, n. 4, p. 363

By:

Khatamifar, M.;
Ranjbar, Z. Rashidi;
Fatemi, S. J.

Publication type:

Article

Deferasirox Nanosuspension Loaded Dissolving Microneedles for Intradermal Delivery.

Published in:

Pharmaceutics, 2022, v. 14, n. 12, p. 2817, doi. 10.3390/pharmaceutics14122817

By:

Faizi, Hafsa Shahid;
Vora, Lalitkumar K.;
Nasiri, Muhammad Iqbal;
Wu, Yu;
Mishra, Deepakkumar;
Anjani, Qonita Kurnia;
Paredes, Alejandro J.;
Thakur, Raghu Raj Singh;
Minhas, Muhammad Usman;
Donnelly, Ryan F.

Publication type:

Article

Fiscalin Derivatives as Potential Neuroprotective Agents.

Published in:

Pharmaceutics, 2022, v. 14, n. 7, p. N.PAG, doi. 10.3390/pharmaceutics14071456

By:

Barreiro, Sandra;
Silva, Bárbara;
Long, Solida;
Pinto, Madalena;
Remião, Fernando;
Sousa, Emília;
Silva, Renata

Publication type:

Article

M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer.

Published in:

Pharmaceutics, 2021, v. 13, n. 9, p. 1493, doi. 10.3390/pharmaceutics13091493

By:

Zhao, Yongmei;
Zheng, Yuanlin;
Zhu, Yan;
Zhang, Yi;
Zhu, Hongyan;
Liu, Tianqing

Publication type:

Article

Effects of Magnesium, Calcium, and Aluminum Chelation on Fluoroquinolone Absorption Rate and Bioavailability: A Computational Study.

Published in:

Pharmaceutics, 2021, v. 13, n. 5, p. 594, doi. 10.3390/pharmaceutics13050594

By:

Walden, Daniel M.;
Khotimchenko, Maksim;
Hou, Hypatia;
Chakravarty, Kaushik;
Varshney, Jyotika;
Gonzalez-Alvarez, Isabel;
Langguth, Peter

Publication type:

Article

Stable Luminescent Poly(Allylaminehydrochloride)-Templated Copper Nanoclusters for Selectively Turn-Off Sensing of Deferasirox in β-Thalassemia Plasma.

Published in:

Pharmaceuticals (14248247), 2021, v. 14, n. 12, p. 1314, doi. 10.3390/ph14121314

By:

Lin, Hung-Ju;
Wang, Chun-Chi;
Kou, Hwang-Shang;
Cheng, Cheng-Wei;
Wu, Shou-Mei

Publication type:

Article

A Solid Ultra Fine Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) of Deferasirox for Improved Solubility: Optimization, Characterization, and In Vitro Cytotoxicity Studies.

Published in:

Pharmaceuticals (14248247), 2020, v. 13, n. 8, p. 162, doi. 10.3390/ph13080162

By:

Alghananim, Alaa;
Özalp, Yıldız;
Mesut, Burcu;
Serakinci, Nedime;
Özsoy, Yıldız;
Güngör, Sevgi

Publication type:

Article

Hemochromatosis in the setting of Chronic Parvovirus B-19 induced Aplastic Anemia.

Published in:

Cancer Therapy, 2011, v. 8, p. 86

By:

Jerkins, James H.;
Calvo, Alejandro R.;
Shrit, M. Atef

Publication type:

Article

A case of transfusion independence in a patient with myelodysplastic syndrome using deferasirox, sustained for two years after stopping therapy.

Published in:

2015

By:

Sanford, D.;
Hsia, C. C.

Publication type:

Case Study

Type-I Hypersensitivity Reaction Secondary to Deferasirox Intake.

Published in:

UHOD: International Journal of Hematology & Oncology / Uluslararasi Hematoloji Onkoloji Dergisi, 2010, v. 20, n. 2, p. 42

By:

Isik, Pamir;
Yarali, Nese;
Bay, Ali;
Ozmen, Serap;
Tunc, Bahattin

Publication type:

Article

Type-I Hypersensitivity Reaction Secondary to Deferasirox Intake.

Published in:

UHOD: International Journal of Hematology & Oncology / Uluslararasi Hematoloji Onkoloji Dergisi, 2010, v. 20, n. 1, p. 42

By:

Isik, Pamir;
Yarali, Nese;
Bay, Ali;
Ozmen, Serap;
Tunc, Bahattin

Publication type:

Article

Introducing a modern chemotherapeutic drug formulated by iron nanoparticles for the treatment of human lung cancer.

Published in:

Journal of Experimental Nanoscience, 2021, v. 16, n. 1, p. 397, doi. 10.1080/17458080.2021.1998460

By:

Bai, Junfeng;
Gongsun, Xin;
Xue, Liangliang;
Zangeneh, Mohammad Mahdi

Publication type:

Article

Nanoflakes of cobalt oxide for highly sensitive sensing of two orally iron chelating drugs deferasirox and deferiprone.

Published in:

Journal of Experimental Nanoscience, 2011, v. 6, n. 5, p. 488, doi. 10.1080/17458080.2010.483694

By:

Heli, H.;
Yadegari, H.;
Karimian, K.

Publication type:

Article

Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox.

Published in:

2023

By:

Amano, Shogo;
Kaino, Seiji;
Shinoda, Shuhei;
Harima, Hirofumi;
Matsumoto, Toshihiko;
Fujisawa, Koichi;
Takami, Taro;
Yamamoto, Naoki;
Yamasaki, Takahiro;
Sakaida, Isao

Publication type:

Correction Notice